UBS Group »

Aldeyra Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $186k 53k 3.51
2023-09-30 $498k 75k 6.68
2023-06-30 $749k 89k 8.39
2023-03-31 $64k 6.4k 9.93
2022-12-31 $13k 1.8k 6.96
2022-09-30 $143k 26k 5.56
2022-06-30 $3.0M 761k 3.99
2022-03-31 $4.3M 960k 4.44
2021-12-31 $793k 204k 3.89
2021-09-30 $1.2M 137k 8.89
2021-06-30 $165k 15k 11.11
2021-03-31 $581k 49k 11.89
2020-12-31 $683k 102k 6.67
2020-09-30 $766k 106k 7.22
2020-06-30 $14k 3.2k 4.44
2020-03-31 $37k 15k 2.47
2019-12-31 $240k 42k 5.77
2019-09-30 $132k 25k 5.26
2019-06-30 $56k 9.3k 6.03
2019-03-31 $117k 13k 9.10
2018-12-31 $106k 13k 8.34
2018-09-30 $155k 11k 13.76
2018-06-30 $57k 7.2k 7.97
2018-03-31 $48k 6.4k 7.45
2017-12-31 $13k 1.9k 6.75
2017-09-30 $9.0k 1.3k 7.12
2017-06-30 $5.0k 1.1k 4.51
2017-03-31 $9.0k 1.8k 4.92
2016-03-31 $12k 2.8k 4.31
2015-12-31 $0 69 0.00
2015-09-30 $9.0k 1.6k 5.66
2015-03-31 $2.0k 209 9.57